Who
Neena M. Patil
EVP & Chief Legal Officer
Company insider
Files Form 4 as: EVP & Chief Legal Officer, Jazz Pharmaceuticals; Director, Teleflex.
In numbers
- Trades disclosed
- 102
- Buys
- 0
- Sells
- 13
- Bought
- $0
- Sold
- $25.8M
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 8 Aug 2019
- Last trade
- 10 Sep 2026
- Last filed
- 14 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 10 Sep 2026filed 14 Sep 2026 | JAZZ Jazz PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $289K1,200 at $240.94 | filing |
| 10 Sep 2026filed 14 Sep 2026 | JAZZ Jazz PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $289K1,200 at $240.94 | filing |
| 30 Jun 2026filed 2 Jul 2026 | JAZZ Jazz PharmaceuticalsPharmaceuticals | SEC FORM 4 Code F | $637K2,678 at $237.72 | filing |
| 30 Jun 2026filed 2 Jul 2026 | JAZZ Jazz PharmaceuticalsPharmaceuticals | SEC FORM 4 Code F | $637K2,678 at $237.72 | filing |
| 10 Jun 2026filed 12 Jun 2026 | JAZZ Jazz PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $278K1,200 at $231.83 | filing |
| 10 Jun 2026filed 12 Jun 2026 | JAZZ Jazz PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $278K1,200 at $231.83 | filing |
| 28 May 2026filed 1 Jun 2026 | JAZZ Jazz PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $282K1,192 at $236.97 | filing |
| 28 May 2026filed 1 Jun 2026 | JAZZ Jazz PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $282K1,192 at $236.97 | filing |
| 15 May 2026filed 19 May 2026 | TFX TeleflexMedical Devices | SEC FORM 4 Code A | —1,090 at $0.00 | filing |
| 15 May 2026filed 19 May 2026 | TFX Teleflexoption or derivative · Medical Devices | SEC FORM 4 Code A | —2,397 at $0.00 | filing |
| 15 May 2026filed 19 May 2026 | TFX Teleflexoption or derivative · Medical Devices | SEC FORM 4 Code A | —2,397 at $0.00 | filing |
| 15 May 2026filed 19 May 2026 | TFX TeleflexMedical Devices | SEC FORM 4 Code A | —1,090 at $0.00 | filing |
| 5 Mar 2026filed 9 Mar 2026 | JAZZ Jazz PharmaceuticalsPharmaceuticals | SEC FORM 4 Code F | $943K5,000 at $188.69 | filing |
| 5 Mar 2026filed 9 Mar 2026 | JAZZ Jazz PharmaceuticalsPharmaceuticals | SEC FORM 4 Code F | $943K5,000 at $188.69 | filing |
| 26 Feb 2026filed 2 Mar 2026 | JAZZ Jazz PharmaceuticalsPharmaceuticals | SEC FORM 4 Code M | $2.3M20,125 at $113.10 | filing |
| 26 Feb 2026filed 2 Mar 2026 | JAZZ Jazz PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $2.2M11,529 at $191.65 | filing |
| 26 Feb 2026filed 2 Mar 2026 | JAZZ Jazz PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $682K3,523 at $193.58 | filing |
| 26 Feb 2026filed 2 Mar 2026 | JAZZ Jazz PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $202K1,061 at $190.00 | filing |
| 26 Feb 2026filed 2 Mar 2026 | JAZZ Jazz PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $105K549 at $190.80 | filing |
| 26 Feb 2026filed 2 Mar 2026 | JAZZ Jazz PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $342K1,784 at $191.88 | filing |
News
Jazz Pharmaceuticals gets Cramer's vote of confidenceJAZZ · aol.com · 14 Oct 2026Critical Analysis: vTv Therapeutics (NASDAQ:VTVT) and Jazz Pharmaceuticals (NASDAQ:JAZZ)JAZZ · tickerreport.com · 12 Oct 2026Cramer's lightning round: 'I'm going to say yes to Jazz Pharmaceuticals'JAZZ · cnbc.com · 10 Oct 2026
0 headlines in the last 90 days name Neena M. Patil; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.